The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Social Phobia: Epidemiology and Cost of Illness
Abstract
Social phobia is a prevalent and debilitating psychiatric disorder. It entails significant economic costs in the form of educational underachievement, increased financial dependency, decreased work productivity, social impairment and poorer quality of life. It is associated with increased prevalence of other psychiatric disorders including depression and alcohol dependence. Its onset is early and typically precedes onset of comorbid disorders. Despite its debilitating effects, social phobia is often unrecognised and is undertreated. The availability of efficacious pharmacological and psychotherapeutic treatments for social phobia makes it imperative to carefully consider the impact of this disorder and to consider the cost effectiveness of available treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The functioning and well-being of depressed patients. Results from the Medical Outcomes Study
Wells, K. B. (1989) · JAMA · doi:10.1001/jama.262.7.914 · Cited by 2,808
The Functioning and Well-being of Depressed Patients: Results From the Medical Outcomes Study
Wells, K. B. (1989) · JAMA · doi:10.1001/jama.1989.03430070062031 · Cited by 2,130
The economic burden of anxiety disorders in the 1990s
Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., Ballenger, J. C., & Fyer, A. J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0702 · Cited by 1,242 · cited 3×
“Over half of this total (54%) was from non-psychiatric expenditures, typically as a result of misutilisation of health services.[39] Patients with anxiety disorders such as panic disorder and generalised anxiety disorders are likely to seek help from medical practitioners to address suspected medical problems.”
Schneier (1992) · doi:10.1001/archpsyc.1992.01820040034004 · Cited by 1,142 · cited 21×
“4.3 Work Impairment In the ECA sample, social phobia was associated with a 2-fold increase in the rate of financial dependency (being on welfare or disability) compared with controls (22 vs 11%).”
InfluentialAgoraphobia, simple phobia, and social phobia in the National Comorbidity Survey
Magee, W. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020077009 · Cited by 996 · cited 16×
“These results were replicated in the NCS study, which found social phobia (controlling for comorbidity) to be associated with decreased productivity at work, but not with increased absenteeism.”
InfluentialWITTCHEN, H.-U., STEIN, M. B., & KESSLER, R. C. (1999) · Psychological Medicine · doi:10.1017/s0033291798008174 · Cited by 745 · cited 3×
“A recent community study conducted in Germany found lifetime and 12-month prevalence rates of 4% and 3%, respectively, for adolescents aged 14 to 17 years.[8] Rates of social phobia are highest in young adults.”
DSM-III Disorders in a Large Sample of Adolescents
McGEE, R., FEEHAN, M., WILLIAMS, S., PARTRIDGE, F., SILVA, P. A., & KELLY, J. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199007000-00016 · Cited by 645 · cited 2×
“[16] More recently, selective serotonin reuptake inhibitors such as paroxetine,[15] fluvoxamine[29]and sertraline[30] have shown efficacy in controlled trials.”
Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia: 12-Week Outcome
Heimberg, R. G., Liebowitz, M. R., Hope, D. A., Schneier, F. R., Holt, C. S., Welkowitz, L. A., Juster, H. R., Campeas, R., Bruch, M. A., Cloitre, M., et al. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1133 · Cited by 585 · cited 2×
“has demonstrated efficacy compared with both control psychotherapy and pill placebo.[33] Studies have compared the best-studied medication (phenelzine) and psychotherapy (CBGT) treatments for social phobia.”
Self-citationBallenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564 · cited 3×
“In this sample, the LSRDS was moderately correlated with clinician ratings of disability, with measures of social phobia symptom severity, andwith relevant dimensions of theSheehan Disability Scale.[45] Wittchen and Beloch[41] administered the LSRDS to their sample of volunteers with pure social phobia.”
InfluentialFunctional impairment in social phobia.
Schneier, F. R., Heckelman, L., Garfinkel, R. S., Campeas, R. B., Fallon, B. A., Gitow, A., Street, L. L., Bene, D. D., & Liebowitz, M. R. (1994) · PubMed · Cited by 534
Self-citation
Research works printed but not linked: 8
- Wacker, 1992, Int J Methods Psychiatr Res, 2, 91
- Ost, 1987, J Abnorm Psychol, 96, 223, 10.1037/0021-843X.96.3.223 · DOI · Paper page
- Gelernter, 1992, J Clin Psychiatry, 53, 23
- Turner, 1986, J Abnorm Psychol, 95, 389, 10.1037/0021-843X.95.4.389 · DOI · Paper page
- Sanderson, 1990, J Abnorm Psychol, 99, 308, 10.1037/0021-843X.99.3.308 · DOI · Paper page
- Schneier, 1994, J Clin Psychiatry, 55, 322
- Lecrubier, 1998, J Clin Psychiatry, 59, 33
- Rice, 1992, Hosp Comm Psychol, 43, 1227
Cited by
Jacobson, N. C., & Newman, M. G. (2017) · Psychological Bulletin · doi:10.1037/bul0000111 · Cited by 576
Social anxiety disorder and stuttering: current status and future directions.
Iverach, L., & Rapee, R. M. (2014) · Journal of Fluency Disorders · doi:10.1016/j.jfludis.2013.08.003 · Cited by 337
The impairments caused by social phobia in the general population: implications for intervention
Kessler, R. C. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s417.2.x · Cited by 322
STINSON, F. S., DAWSON, D. A., PATRICIA CHOU, S., SMITH, S., GOLDSTEIN, R. B., JUNE RUAN, W., & GRANT, B. F. (2007) · Psychological Medicine · doi:10.1017/s0033291707000086 · Cited by 320
The lifelong course of social anxiety disorder: a clinical perspective
Keller, M. B. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s417.6.x · Cited by 165
Metadata
- Authors
- Lipsitz, J. D., & Schneier, F. R.
- Affiliations
- New York State Psychiatric Institute (US)
- Corresponding author
- Lipsitz, Joshua D.
- Venue
- PharmacoEconomics
- Published
- 2000-07
- Volume
- 18
- Issue
- 1
- Pages
- 23-32
- ISSN
- 1170-7690 (ISSN-L)
- OpenAlex
- W2081735821
- Cited by
- 92
- References
- 48
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 5 · 2016: 7 · 2015: 2 · 2014: 4 · 2013: 5 · 2012: 1
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PharmacoEconomics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- social anxiety disorder, economic burden, quality of life, comorbidities, depression, alcoholism, treatment costs, cost-effectiveness, underdiagnosis, labor productivity
- MeSH terms
- Humans, Phobic Disorders, Comorbidity, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Social Phobia: Epidemiology and Cost of Illness. https://app.cochat.ai/papers/10.2165/00019053-200018010-00003
- The paper
- Lipsitz, J. D., & Schneier, F. R. (2000). Social Phobia: Epidemiology and Cost of Illness. PharmacoEconomics. https://doi.org/10.2165/00019053-200018010-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.